Cleary Gottlieb Steen & Hamilton (Washington)

Bruce Hoffman

Cleary Gottlieb Steen & Hamilton (Washington)
Lawyer (Partner)

Bruce joined the firm as a partner after serving as Director of the Federal Trade Commission’s Bureau of Competition from August 2017 until late December of 2019. As Director, he was the head of the FTC’s antitrust enforcement and was responsible for developing Bureau policy, supervising all of the Bureau’s investigations and litigation, and conducting high-level relations with other leading antitrust enforcers, including the U.S. Department of Justice Antitrust Division, the Directorate-General for Competition of the European Commission and other international enforcers, and state Attorneys General, as well as communications with Congress. Bruce also spearheaded the creation of the Bureau of Competition’s Technology Task Force (now known as the Technology Enforcement Division) to monitor competition in U.S. technology markets, investigate potential anticompetitive conduct in those markets, and take enforcement actions when warranted. Bruce’s role as Bureau Director was his second stint at the FTC. He previously served at the agency from 2001-2004, starting as Associate Director for Regional Litigation and then being elevated to Deputy Director of the Bureau of Competition. In these roles, Bruce oversaw the Bureau’s programs, activities, and investigations. He also led numerous high-profile cases involving mergers, price fixing, monopolization, conspiracies, and other issues in a broad range of industries, and he participated in amicus brief efforts before the U.S. Supreme Court. Prior to joining the FTC in 2001, and then again from 2005 to 2017, Bruce developed and led successful antitrust practices as a partner at leading global law firms. Bruce had an extensive merger review practice, including transactions before the DOJ, FTC, EC, several U.S. states, and other enforcers. He also has wide-ranging experience in high-profile antitrust litigation and investigations, including representing clients in some of the largest antitrust class actions ever filed, as well as competitor lawsuits and conduct investigations. Bruce has handled every aspect of federal and state court litigation, including appellate arguments, jury and bench trials, and numerous court hearings and arguments, as well as arbitration proceedings.

Linked authors

Cleary Gottlieb Steen & Hamilton (Brussels)
Cleary Gottlieb Steen & Hamilton (Washington)
Cleary Gottlieb Steen & Hamilton (Washington)
Cleary Gottlieb Steen & Hamilton (Washington)
Cleary Gottlieb Steen & Hamilton (Washington)


5997 Bulletin

Leah Brannon, Brian R. Byrne, Jeremy J. Calsyn, George S. Cary, Alexis Collins, Daniel P. Culley, Elaine Ewing, David I. Gelfand, Bruce Hoffman, Mark W. Nelson, Kenneth Reinker The US FTC issues commentary on vertical merger enforcement explaining the approach to assessing the competitive effects of vertical mergers


On December 22, 2020, the US Federal Trade Commission (the “FTC”) issued a Commentary on Vertical Merger Enforcement. This follows the recent issuance of revised Vertical Merger Guidelines published jointly by the FTC and Department of Justice (the “Agencies”) on June 30, 2020. While the Guidelines (...)

George S. Cary, Maurits Dolmans, Bruce Hoffman, Thomas Graf, Leah Brannon, Richard Pepper, Henry Mostyn, Alexis R. B. Lazda, Savannah Haynes, Kristi Georgieva, Jan Przerwa Exploitative abuses, price gouging & COVID-19: The cases pursued by EU and national competition authorities


The COVID-19 pandemic has led to extreme demand and price volatility for certain products, as well as fluctuations in firms’ costs. As firms struggle to manage these changes, agencies are aggressively seeking to show they are preventing consumer exploitation—for example, as a result of (...)

Alexis R. B. Lazda, Savannah Haynes, Bruce Hoffman, Richard Pepper, Konstantin Bondarenko, Wanjie Lin, Anita Ng The World’s Authorities present steps to minimise the impact of COVID-19 on antitrust related issues that businesses may confront in the coming days of the outbreak


I. INTRODUCTION The COVID-19 pandemic presents unprecedented issues for businesses and we recognize that antitrust is unlikely to be your most important concern at this time. However, some forethought may mitigate risk of future exposure, and position your business as well as possible in this (...)

Send a message